Industry News
Vismodegib For Treatment Of Patients With Basal Cell Carcinoma
Jun 11, 2012
According to results from the pivotal Phase II ERIVANCE BCC trial, up to 2,000 individuals suffering from advanced basal cell carcinoma (aBCC) in the UK could significantly benefit from a once a day pill called vismodegib... Read More
Perjeta For Breast Cancer Gets Roche's Genentech An FDA Approval
Jun 11, 2012
Last week, Roche and Genentech announced results from its Phase III trial of trastuzumab emtansine (T-DM1) which slows progress of metastatic breast cancer, they hope to have FDA approval later in the year. In further news, Perjeta, also for treating breast cancer, has been given FDA approval also for treating HER2-postive late-stage (metastatic) breast cancer... Read More
Perjeta For Breast Cancer Gets Roche's Genentech An FDA Approval
Jun 11, 2012
Last week, Roche and Genentech announced results from its Phase III trial of trastuzumab emtansine (T-DM1) which slows progress of metastatic breast cancer, they hope to have FDA approval later in the year. In further news, Perjeta, also for treating breast cancer, has been given FDA approval also for treating HER2-postive late-stage (metastatic) breast cancer... Read More
Early Tumor Shrinkage With Cetuximab Correlates With Prolonged Survival In Metastatic Colorectal Cancer
Jun 11, 2012
Early tumor shrinkage in patients with metastatic colorectal cancer treated first line with the EGFR inhibitor cetuximab (Erbitux) is associated with prolonged survival, show results reported at the American Society of Clinical Oncology annual meeting (1-5 June 2012; Chicago, USA)... Read More
CARE Act Hearing: Immediate Passage Of Bill Encouraged To Ensure Safe Cancer Treatments
Jun 11, 2012
American Society for Radiation Oncology (ASTRO) Chairman Leonard Gunderson, MD, MS, FASTRO, has testifeid before the House Committee on Energy and Commerce Subcommittee on Health on provisions of the Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (CARE Act) related to training and credentialing for medical imaging and ... Read More
CARE Act Hearing: Immediate Passage Of Bill Encouraged To Ensure Safe Cancer Treatments
Jun 11, 2012
American Society for Radiation Oncology (ASTRO) Chairman Leonard Gunderson, MD, MS, FASTRO, has testifeid before the House Committee on Energy and Commerce Subcommittee on Health on provisions of the Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (CARE Act) related to training and credentialing for medical imaging and ... Read More
Chemotherapy Resistance And Overexpression Of Proteins 14-3-3
Jun 11, 2012
Certain proteins, such as 14-3-3, conserve their basic functions of cell cycle control in diverse organisms, from worms to humans... Read More
Researchers Develop And Test New Anti-Cancer Vaccine
Jun 11, 2012
Researchers at Moffitt Cancer Center have developed and tested in mice a synthetic vaccine and found it effective in killing human papillomavirus-derived cancer, a virus linked to cervical cancers among others. The research was published in a recent issue of Cancer Immunology, Immunotherapy... Read More
Researchers Develop And Test New Anti-Cancer Vaccine
Jun 11, 2012
Researchers at Moffitt Cancer Center have developed and tested in mice a synthetic vaccine and found it effective in killing human papillomavirus-derived cancer, a virus linked to cervical cancers among others. The research was published in a recent issue of Cancer Immunology, Immunotherapy... Read More
Pioneering Use Of Fruit Flies To Identify A Drug That Targets Cancer
Jun 11, 2012
Researchers from Mount Sinai School of Medicine developed a cancer model built in the fruit fly Drosophila, then used it to create a whole new approach to the discovery of cancer treatments. The result is an investigational compound AD80 that precisely targets multiple cancer genes... Read More
Previous Page Next Page